Dihydroartemisinin is a hypoxia active anticancer drug

被引：2
|
作者：
Ontikatze, T. [1 ]
Handrick, R. [1 ]
Grimm, F. [1 ]
Henke, G. [2 ]
Daniel, P. T. [3 ]
Belka, C. [2 ]
Jendrossek, V. [1 ]
机构：
[1] Univ Hosp Duisburg Essen, Essen, Germany
[2] Univ Tubingen, Tubingen, Germany
[3] Univ Med Berlin, Berlin, Germany
来源：
EJC SUPPLEMENTS | 2010年 / 8卷 / 05期
关键词：
D O I：
10.1016/S1359-6349(10)71170-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
369
引用
收藏
页码：94 / 94
页数：1
相关论文
共 50 条
  • [1] Dihydroartemisinin is a hypoxia active anticancer drug that interferes with the cytotoxic action of radiotherapy
    Ontikatze, T.
    Handrick, R.
    Grimm, F.
    Henke, G.
    Daniel, P. T.
    Belka, C.
    Jendrossek, V.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 121 - 122
  • [2] Dihydroartemisinin is a potent anticancer drug active in hypoxic conditions
    Ontikatze, Teona
    Handrick, Rene
    Bauer, Kerstin-Daniela
    Freier, Florian
    Ruebel, Amelie
    Belka, Claus
    Jendrossek, Verena
    CANCER RESEARCH, 2009, 69
  • [3] Dihydroartemisinin: A Potential Natural Anticancer Drug
    Dai, Xiaoshuo
    Zhang, Xiaoyan
    Chen, Wei
    Chen, Yihuan
    Zhang, Qiushuang
    Mo, Saijun
    Lu, Jing
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2021, 17 (02): : 603 - 622
  • [4] Dihydroartemisinin is a hypoxia-active anti-cancer drug in colorectal carcinoma cells
    Ontikatze, Teona
    Rudner, Justine
    Handrick, Rene
    Belka, Claus
    Jendrossek, Verena
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [5] Tirapazamine: a bioreductive anticancer drug that exploits tumour hypoxia
    Denny, WA
    Wilson, WR
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (12) : 2889 - 2901
  • [6] Hypoxia-Activated Anticancer Prodrug for Bioimaging, Tracking Drug Release, and Anticancer Application
    Liu, Wei
    Liu, Haitong
    Peng, Xiaoran
    Zhou, Guoqiang
    Liu, Dandan
    Li, Shenghui
    Zhang, Jinchao
    Wang, Shuxiang
    BIOCONJUGATE CHEMISTRY, 2018, 29 (10) : 3332 - 3343
  • [7] Active Targeting Strategies for Anticancer Drug Nanocarriers
    Basile, Livia
    Pignatello, Rosario
    Passirani, Catherine
    CURRENT DRUG DELIVERY, 2012, 9 (03) : 255 - 268
  • [8] Dihydroartemisinin-Bile Acid Hybridization as an Effective Approach to Enhance Dihydroartemisinin Anticancer Activity
    Marchesi, Elena
    Chinaglia, Nicola
    Capobianco, Massimo L.
    Marchetti, Paolo
    Huang, Tzu-En
    Weng, Hao-Cheng
    Guh, Jih-Hwa
    Hsu, Lih-Ching
    Perrone, Daniela
    Navacchia, Maria Luisa
    CHEMMEDCHEM, 2019, 14 (07) : 779 - 787
  • [9] Hypoxia modulates the effect of dihydroartemisinin on endothelial cells
    D'Alessandro, S.
    Basilico, N.
    Corbett, Y.
    Scaccabarozzi, D.
    Omodeo-Sale, F.
    Saresella, M.
    Marventano, I.
    Vaillant, M.
    Olliaro, P.
    Taramelli, D.
    BIOCHEMICAL PHARMACOLOGY, 2011, 82 (05) : 476 - 484
  • [10] Potentialization of anticancer agents by identification of new chemosensitizers active under hypoxia
    Marx, Sebastien
    Van Gysel, Megane
    Breuer, Aurelie
    Dal Maso, Thomas
    Michiels, Carine
    Wouters, Johan
    Le Calve, Benjamin
    BIOCHEMICAL PHARMACOLOGY, 2019, 162 : 224 - 236
12345